FCGRT and cancer: In spite of the extensive tissue damage that results from FcRn-mediated intestinal inflammation, however, WT mice are significantly protected from the development of inflammation-associated CRC in comparison to their Fcgrt−/− littermates in whom the protection from FcRn-mediated inflammation translated into dampened anti-cancer immunity (113).